학술논문

Blood CD9+B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation
Document Type
Article
Author
Brosseau, CaroleDanger, RichardDurand, MaximDurand, EugénieFoureau, AuroreLacoste, PhilippeTissot, AdrienRoux, AntoineReynaud‐Gaubert, MartineKessler, RomainMussot, SachaDromer, ClaireBrugière, OlivierMornex, Jean FrançoisGuillemain, RomainClaustre, JohannaMagnan, AntoineBrouard, SophieJougon, J.Velly, J.‐F.Rozé, H.Blanchard, E.Antoine, M.Cappello, M.Ruiz, M.Sokolow, Y.Vanden Eynden, FVan Nooten, G.Barvais, L.Berré, J.Brimioulle, S.De Backer, D.Créteur, J.Engelman, EHuybrechts, I.Ickx, B.Preiser, T.J.C.Tuna, T.Van Obberghe, L.Vancutsem, N.Vincent, J.‐L.De Vuyst, P.Etienne, I.Féry, F.Jacobs, F.Knoop, C.Vachiéry, J.L.Van den Borne, P.Wellemans, I.Amand, G.Collignon, L.Giroux, M.Angelescu, D.Chavanon, O.Hacini, R.Martin, C.Pirvu, A.Porcu, P.Albaladejo, P.Allègre, C.Bataillard, A.Bedague, D.Briot, E.Casez‐Brasseur, M.Colas, D.Dessertaine, G.Francony, G.Hebrard, A.Marino, M.R.Protar, D.Rehm, D.Robin, SRossi‐Blancher, M.Augier, C.Bedouch, P.Boignard, A.Bouvaist, H.Briault, A.Camara, B.Chanoine, S.Dubuc, M.Quétant, S.Maurizi, J.Pavèse, P.Pison, C.Saint‐Raymond, C.Wion, N.Chérion, C.Grima, R.Jegaden, O.Maury, J.‐M.Tronc, F.Flamens, C.Paulus, S.Philit, F.Senechal, A.Glérant, J.‐C.Turquier, S.Gamondes, D.Chalabresse, L.Thivolet‐Bejui, F.Barnel, C.Dubois, C.Tiberghien, A.Pimpec‐Barthes, F.Bel, A.Mordant, P.Achouh, P.Boussaud, V.Méléard, D.Bricourt, M.O.Cholley, B.Pezella, V.Brioude, G.D'Journo, X.B.Doddoli, C.Thomas, P.Trousse, D.Dizier, S.Leone, M.Papazian, L.Bregeon, F.Coltey, B.Dufeu, N.Dutau, H.Garcia, S.Gaubert, J.Y.Gomez, C.Laroumagne, S.Mouton, G.Nieves, A.Picard, Ch.Rolain, J.M.Sampol, E.Secq, V.Perigaud, C.Roussel, J.C.Senage, T.Mugniot, A.Danner, I.Haloun, A.Abbes, S.Bry, C.Blanc, F.X.Lepoivre, T.Botturi‐Cavaillès, K.Loy, J.Bernard, M.Godard, E.Royer, P.‐J.Henrio, K.Dartevelle, Ph.Fabre, D.Fadel, E.Mercier, O.Stephan, F.Viard, P.Cerrina, J.Dorfmuller, P.Feuillet, S.Ghigna, M.Hervén, Ph.Le Roy Ladurie, F.Le Pavec, J.Thomas de Montpreville, V.Lamrani, L.Castier, Y.Mordant, P.Cerceau, P.Augustin, P.Jean‐Baptiste, S.Boudinet, S.Montravers, P.Dauriat, G.Jébrak, G.Mal, H.Marceau, A.Métivier, A.‐C.Thabut, G.Lhuillier, E.Dupin, C.Bunel, V.Falcoz, P.Massard, G.Santelmo, N.Ajob, G.Collange, O.Helms, O.Hentz, J.Roche, A.Bakouboula, B.Degot, T.Dory, A.Hirschi, S.Ohlmann‐Caillard, S.Kessler, L.Schuller, A.Bennedif, K.Vargas, S.Bonnette, P.Chapelier, A.Puyo, P.Sage, E.Bresson, J.Caille, V.Cerf, C.Devaquet, J.Dumans‐Nizard, V.Felten, M.L.Fischler, M.Si Larbi, A.G.Leguen, M.Ley, L.Liu, N.Trebbia, G.De Miranda, S.Douvry, B.Gonin, F.Grenet, D.Hamid, A.M.Neveu, H.Parquin, F.Picard, C.Stern, M.Bouillioud, F.Cahen, P.Colombat, M.Dautricourt, C.Delahousse, M.D'Urso, B.Gravisse, J.Guth, A.Hillaire, S.Honderlick, P.Lequintrec, M.Longchampt, E.Mellot, F.Scherrer, A.Temagoult, L.Tricot, L.Vasse, M.Veyrie, C.Zemoura, L.Dahan, M.Murris, M.Benahoua, H.Berjaud, J.Le Borgne Krams, A.Crognier, L.Brouchet, L.Mathe, O.Didier, A.Krueger, T.Ris, H.B.Gonzalez, M.Aubert, J.‐D.Nicod, L.P.Marsland, B.J.Berutto, T.C.Rochat, T.Soccal, P.Jolliet, Ph.Koutsokera, A.Marcucci, C.Manuel, O.Bernasconi, E.Chollet, M.Gronchi, F.Courbon, C.Hillinger, S.Inci, I.Kestenholz, P.Weder, W.Schuepbach, R.Zalunardo, M.Benden, C.Buergi, U.Huber, L.C.Isenring, B.Schuurmans, M.M.Gaspert, A.Holzmann, D.Müller, N.Schmid, C.Vrugt, B.Rechsteiner, T.Fritz, A.Maier, D.Deplanche, K.Koubi, D.Ernst, F.Paprotka, T.Schmitt, M.Wahl, B.Boissel, J.‐P.Olivera‐Botello, G.Trocmé, C.Toussaint, B.Bourgoin‐Voillard, S.Séve, M.Benmerad, M.Siroux, V.Slama, R.Auffray, C.Charron, D.Lefaudeux, D.Pellet, J.
Source
American Journal of Transplantation; November 2019, Vol. 19 Issue: 11 p3162-3175, 14p
Subject
Language
ISSN
16006135; 16006143
Abstract
Bronchiolitis obliterans syndrome is the main limitation for long‐term survival after lung transplantation. Some specific B cell populations are associated with long‐term graft acceptance. We aimed to monitor the B cell profile during early development of bronchiolitis obliterans syndrome after lung transplantation. The B cell longitudinal profile was analyzed in peripheral blood mononuclear cells from patients with bronchiolitis obliterans syndrome and patients who remained stable over 3 years of follow‐up. CD24hiCD38hitransitional B cells were increased in stable patients only, and reached a peak 24 months after transplantation, whereas they remained unchanged in patients who developed a bronchiolitis obliterans syndrome. These CD24hiCD38hitransitional B cells specifically secrete IL‐10 and express CD9. Thus, patients with a total CD9+B cell frequency below 6.6% displayed significantly higher incidence of bronchiolitis obliterans syndrome (AUC = 0.836, PPV = 0.75, NPV = 1). These data are the first to associate IL‐10‐secreting CD24hiCD38hitransitional B cells expressing CD9 with better allograft outcome in lung transplant recipients. CD9‐expressing B cells appear as a contributor to a favorable environment essential for the maintenance of long‐term stable graft function and as a new predictive biomarker of bronchiolitis obliterans syndrome–free survival. In lung transplant patients with bronchiolitis obliterans syndrome and patients who remained stable over 3 years of follow‐up, IL‐10–secreting CD24hiCD38hi transitional B cells expressing CD9 are associated with better allograft outcome, suggesting CD9‐expressing B cells as a new predictive biomarker of bronchiolitis obliterans syndrome–free survival.